Expertise in
1
conditions

Johana Pradelli

Nice, FR 
Expertise in
1
conditions
Nice, FR 

Overview

Johana Pradelli practices practicing medicine in Nice, France.

Ms. Pradelli is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Swyer-James Syndrome, Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH), Brain Abscess, and ADULT Syndrome.

She is actively involved in clinical research, co-authoring 8 peer reviewed articles and participating in 6 clinical trials.

Gender

Female

Locations

Nice, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Completed
Publish Date: May 18, 2026
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3
Efficiency and Acceptability of SIMEOX® Used Autonomously at Home for Bronchial Clearance in Patients With Cystic Fibrosis: Prospective, Randomized Controlled Study
Efficiency and Acceptability of SIMEOX® Used Autonomously at Home for Bronchial Clearance in Patients With Cystic Fibrosis: Prospective, Randomized Controlled Study
Enrollment Status: Completed
Publish Date: June 11, 2025
Intervention Type: Device
Study Phase: Not Applicable
An Atlas of Airways at a Single Cell Level in Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Controls
An Atlas of Airways at a Single Cell Level in Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Controls
Enrollment Status: Completed
Publish Date: March 24, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
Enrollment Status: Completed
Publish Date: December 17, 2024
Intervention Type: Drug, Biological
Study Drug: GSK3511294
Study Phase: Phase 3
Project A4sc - An Atlas of Airways at a Single Cell Level
Project A4sc - An Atlas of Airways at a Single Cell Level
Enrollment Status: Completed
Publish Date: February 06, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Efficiency and Acceptability of SIMEOX® Used Autonomously at Home for Bronchial Clearance in Patients With Cystic Fibrosis: Ancillary Study
Efficiency and Acceptability of SIMEOX® Used Autonomously at Home for Bronchial Clearance in Patients With Cystic Fibrosis: Ancillary Study
Enrollment Status: Completed
Publish Date: January 04, 2022
Intervention Type: Device
Study Phase: Not Applicable
View 5 Less Clinical Trials

8 Total Publications

A contemporary picture of bacterial infections in patients with hereditary hemorrhagic telangiectasia: A nationwide cohort study.
A contemporary picture of bacterial infections in patients with hereditary hemorrhagic telangiectasia: A nationwide cohort study.
Journal: The Journal of infection
Published: October 23, 2025

Frequently Asked Questions about Johana Pradelli

Is Johana Pradelli a top-rated expert for Swyer-James Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Johana Pradelli is classified as an Advanced expert for Swyer-James Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Johana Pradelli participate in research or clinical trials?

Yes. Johana Pradelli has published 8 articles and abstracts on conditions like Swyer-James Syndrome. You can view a list of Johana Pradelli's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Pradelli's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile